article thumbnail

RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring

DAIC

RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. RCE Technologies, Inc. Featured in an ACC.24

article thumbnail

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

DAIC

This is the world’s first AI that can detect life-threatening cardiac conditions, including heart attacks, using a reduced leadset. KAI 12L can seamlessly integrate with compatible devices, including the Kardia 12L ECG System, expanding critical access to accurate heart data within a broad range of healthcare settings.

article thumbnail

Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System

DAIC

Its purpose is to support physicians with a more accurate and personalized risk assessment for patients at risk of major adverse cardiovascular events (MACE), including heart attacks, before they happen. Min , MD, Founder and CEO of Cleerly.

article thumbnail

Bridging the Gap: Enhancing Stroke Recovery Through Digital Health Solutions

DAIC

With the rise of digital health, innovative solutions are emerging that can significantly impact patient care and recovery while simultaneously addressing health equity. I had had a heart attack previously. After the stroke, I had new prescriptions, and this was the first obstacle for me.

Strokes 115
article thumbnail

Mobile app tracking blood pressure helps patients in Ghana

Medical Xpress - Cardiology

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that was developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results in tests with patients at high risk for heart attack or stroke.

article thumbnail

Clipping Spline Technique Progresses Reproductive Health and Cardiac Development Research

DAIC

An improved understanding of heart development could help inform new clinical strategies in managing congenital heart diseases, which are the most common type of birth defects, said research team leader Shang Wang from Stevens Institute of Technology.

article thumbnail

Smidt Heart Institute Physicians Advance Transcatheter Tricuspid Valve Replacement

DAIC

Photo by Cedars-Sinai Raj Makkar, MD , associate director of the Smidt Heart Institute and vice president of Cardiovascular Innovation and Intervention for Cedars-Sinai, was the principal investigator for the TRISCEND II trial at Cedars-Sinai. Raj Makkar, MD. Moderate and severe tricuspid disease is common in the U.S.

Tricuspid 105